Evidence map›Paper›PMID 32156724›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Arrestin domain-containing 3 (Arrdc3) modulates insulin action and glucose metabolism in liver.

Thiago M Batista, Sezin Dagdeviren, Shannon H Carroll, Weikang Cai, Veronika Y Melnik, Hye Lim Noh, Suchaorn Saengnipanthkul, Jason K Kim, C Ronald Kahn, Richard T Lee

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Thiago M BatistaSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215.
Sezin DagdevirenDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
Shannon H CarrollDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
Weikang CaiSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215.
Veronika Y MelnikDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
Hye Lim NohProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655.
Suchaorn SaengnipanthkulProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655.
Jason K KimProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655.
C Ronald KahnSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215; c.ronald.kahn@joslin.harvard.edu richard_lee@harvard.edu.
Richard T LeeDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138; c.ronald.kahn@joslin.harvard.edu richard_lee@harvard.edu.ORCID 0000-0003-4687-1381
Harvard University · USJoslin Diabetes Center · USUniversity of Massachusetts Chan Medical School · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 1986 to 2026
$50.5M
INSULIN RECEPTOR STRUCTURE AND TURNOVERR37DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 2000 to 2019
$12.9M
Insulin Receptor Substrates and Insulin ActionR01DK033201 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 1986 to 2016
$10.6M
UMass Mouse Metabolic Phenotyping Center - Metabolism CoreU2CDK093000 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIM, JASON K · 2016 to 2021
$4.6M
The Insulin Receptor and Its Signaling MechanismsR01DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI C RONALD KAHN · 1986 to 2026
$4.2M
UMass Mouse Metabolic Phenotyping CenterU24DK093000 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIM, JASON K · 2011 to 2015
$2.1M
Regulation of Fructose Transport by Thioredoxin-Interacting ProteinR01DK107396 · NIDDK · HARVARD UNIVERSITY · PI LEE, RICHARD T · 2016 to 2020
$1.9M
Interleukin-10 and Regulation of Skeletal Muscle Insulin ActionR01DK080756 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIM, JASON K · 2008 to 2012
$1.6M
Regulation of neural function by astrocyte insulin and IGF-1 receptor signalingK01DK120740 · NIDDK · NEW YORK INST OF TECHNOLOGY · PI CAI, WEIKANG · 2019 to 2021
$439k
The role of adipocyte alpha-arrestin ARRDC3 in obesityF32DK105682 · NIDDK · HARVARD UNIVERSITY · PI CARROLL, SHANNON · 2015 to 2016
$112k
NIDDK NIH HHS F32 DK105682NIDDK NIH HHS K01 DK120740NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK031036NIDDK NIH HHS R01 DK033201NIDDK NIH HHS R01 DK080756NIDDK NIH HHS R01 DK107396NIDDK NIH HHS R37 DK031036NIDDK NIH HHS U24 DK093000NIDDK NIH HHS U2C DK093000
6 · The paper itself

Abstract

Insulin action in the liver is critical for glucose homeostasis through regulation of glycogen synthesis and glucose output. Arrestin domain-containing 3 (

Indexed as

Insulin ResistanceAnimalsArrestinsCell MembraneForkhead Box Protein O1GlucoseHypoglycemic AgentsInsulinLiverMiceMice, Inbred C57BLMice, KnockoutPhosphorylationReceptor, InsulinARRDC3 protein, mouseArrestinsForkhead Box Protein O1Foxo1 protein, mouseGlucoseHypoglycemic AgentsInsulinReceptor, Insulinalpha arrestinsArrdc3glucose metabolisminsulin actionliver

Identifiers

PMID32156724
PMCPMC7104271
OpenAlexW3012213717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.